ELICIO THERAPEUTICS INC(NASDAQ:ELTX) stock News

ELTX Latest News, Press Relases and Analysis

All

Press Releases

8 days ago - By: Elicio Therapeutics Inc.

Elicio Therapeutics Reports Inducement Grants

8 days ago - By: Elicio Therapeutics Inc.

Elicio Therapeutics Reports Inducement Grants

9 days ago - By: Elicio Therapeutics Inc.

Elicio Therapeutics Reports ELI-002 7P Achieved Robust mKRAS-Specific T Cell Responses in 99% of Evaluable Patients in Ongoing Phase 2 AMPLIFY-7P Trial

9 days ago - By: Elicio Therapeutics Inc.

Elicio Therapeutics Reports ELI-002 7P Achieved Robust mKRAS-Specific T Cell Responses in 99% of Evaluable Patients in Ongoing Phase 2 AMPLIFY-7P Trial

2 months ago - By: The Motley Fool

Elicio (ELTX) Q2 Loss Beats Estimates

a month ago - By: Elicio Therapeutics Inc.

Elicio Therapeutics Announces Publication of ELI-002 Updated AMPLIFY-201 Phase 1 Follow-up Data in Nature Medicine for Minimal Residual Disease (“MRD”) Positive, Adjuvant-Stage Patients

a month ago - By: Elicio Therapeutics Inc.

Elicio Therapeutics Announces Publication of ELI-002 Updated AMPLIFY-201 Phase 1 Follow-up Data in Nature Medicine for Minimal Residual Disease (“MRD”) Positive, Adjuvant-Stage Patients

2 months ago - By: Elicio Therapeutics Inc.

Elicio Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Updates

2 months ago - By: Elicio Therapeutics Inc.

Elicio Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Updates

2 months ago - By: Elicio Therapeutics Inc.

Elicio Therapeutics Announces Positive Recommendation by IDMC to Continue ELI-002 7P Randomized Phase 2 Study in Pancreatic Cancer Without Modifications to Final Analysis

2 months ago - By: Benzinga - Mentions: ALGN DYAI MDXG HCTI ...

12 Health Care Stocks Moving In Wednesday's After-Market Session

2 months ago - By: Yahoo Finance - Mentions: AUTL

Unlocking Oncology’s Future: 3 Trending Cancer Biotech Stocks with ‘Strong Buy’ Ratings

3 months ago - By: Elicio Therapeutics Inc.

Elicio Therapeutics to Host Virtual KOL Event on June 25, 2025 to Discuss AMP-Powered ELI-002 for the Treatment of KRAS mutation-driven Pancreatic Cancer

3 months ago - By: Elicio Therapeutics Inc.

Elicio Therapeutics to Host Virtual KOL Event on June 25, 2025 to Discuss AMP-Powered ELI-002 for the Treatment of KRAS mutation-driven Pancreatic Cancer

4 months ago - By: Elicio Therapeutics Inc.

Elicio Therapeutics Secures $10 Million in Financing

4 months ago - By: Elicio Therapeutics Inc.

Elicio Therapeutics Secures $10 Million in Financing

5 months ago - By: Elicio Therapeutics Inc.

Elicio Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Updates

5 months ago - By: Elicio Therapeutics Inc.

Elicio Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Updates

5 months ago - By: Zacks Investment Research

Here's Why Elicio Therapeutics (ELTX) Could be Great Choice for a Bottom Fisher

5 months ago - By: Elicio Therapeutics Inc.

Elicio Therapeutics Reports Inducement Grant to New Chief Strategy and Financial Officer and Other New Hires

5 months ago - By: Elicio Therapeutics Inc.

Elicio Therapeutics Reports Inducement Grant to New Chief Strategy and Financial Officer and Other New Hires

6 months ago - By: Yahoo Finance - Mentions: GME NKE LLY NVO

Why GameStop Stock Popped 11% Friday as Stock Indexes Fell

6 months ago - By: Benzinga - Mentions: CORT CTXR RSLS YCBD ...

12 Health Care Stocks Moving In Tuesday's Intraday Session

6 months ago - By: Elicio Therapeutics Inc.

Elicio Therapeutics Reports 2024 Financial Results and Provides Corporate Updates

6 months ago - By: Elicio Therapeutics Inc.

Elicio Therapeutics Reports 2024 Financial Results and Provides Corporate Updates

6 months ago - By: Elicio Therapeutics Inc.

Elicio Therapeutics Appoints Preetam Shah, Ph.D., MBA, as Chief Strategy and Financial Officer

8 months ago - By: Elicio Therapeutics Inc.

Elicio Therapeutics Announces $10.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

8 months ago - By: Elicio Therapeutics Inc.

Elicio Therapeutics Reaches Alignment with FDA on ELI-002 Registrational Strategy

8 months ago - By: Elicio Therapeutics Inc.

Elicio Therapeutics Reaches Alignment with FDA on ELI-002 Registrational Strategy

10 months ago - By: Elicio Therapeutics Inc.

Elicio Therapeutics Presents Updated Results from ELI-002 Phase 1 AMPLIFY-201 Study at ESMO Immuno-Oncology Congress 2024

10 months ago - By: Elicio Therapeutics Inc.

Elicio Therapeutics Presents Updated Results from ELI-002 Phase 1 AMPLIFY-201 Study at ESMO Immuno-Oncology Congress 2024

10 months ago - By: Elicio Therapeutics Inc.

Elicio Therapeutics Announces Completion of Phase 2 AMPLIFY-7P Study Enrollment

10 months ago - By: Elicio Therapeutics Inc.

Elicio Therapeutics Announces Completion of Phase 2 AMPLIFY-7P Study Enrollment

11 months ago - By: Elicio Therapeutics Inc.

Elicio Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

11 months ago - By: Elicio Therapeutics Inc.

Elicio Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

a year ago - By: Elicio Therapeutics Inc.

Elicio Therapeutics Presents Updated Translational Data from ELI-002 Phase 1 AMPLIFY-7P Study at the Society for Immunotherapy of Cancer (“SITC”) 2024 Annual Meeting

ELICIO THERAPEUTICS INC (ELTX) Stock News

ELTX Latest News, Press Relases and Analysis